Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Opinion|Videos|May 28, 2024

Navigating Financial Barriers: Cost-Saving Strategies and Patient Assistance Programs

Author(s)Ryan Haumschild, PharmD, MS, MBA, Heather Moore, BCOP, CPP, PharmD, Britny Brown, PharmD, BCOP

Frank Scimeca, PharmD, MBA, BCOP, discusses strategies for implementing cost-saving measures and utilizing patient assistance programs to help patients access therapy, while emphasizing the importance of mitigating financial toxicities for patients.

Episodes in this series

Aimee Keegan, PharmD, BCOP, a clinical pharmacist

EP. 1 Optimizing Adherence to CDK4/6 Inhibitors in Metastatic Breast Cancer

Aimee Keegan, PharmD, BCOP, a clinical pharmacist

EP. 2 Institutional Insights on CDK4/6 Inhibitor Adherence in Breast Cancer

Aimee Keegan, PharmD, BCOP, a clinical pharmacist

EP. 3 CDK4/6 Inhibitors as First-Line Options in Metastatic Breast Cancer

Aimee Keegan, PharmD, BCOP, a clinical pharmacist

EP. 4 Treatment Algorithms for Early and Metastatic Breast Cancer

Aimee Keegan, PharmD, BCOP, a clinical pharmacist

EP. 5 NATALEE: Ribociclib and Endocrine Therapy in HR+/HER2- Early Breast Cancer

Video - "Evaluating the Impact of Metastatic Breast Cancer on Patients"

EP. 6 Evaluating the Impact of Metastatic Breast Cancer on Patients

Video 2 - "Highlighting the Available CDK4/6 Inhibitors"

EP. 7 Highlighting the Available CDK4/6 Inhibitors

EP. 8 Strategies to Enhance CDK4/6 Inhibitor Adherence in mBC

EP. 8 Strategies to Enhance CDK4/6 Inhibitor Adherence in mBC

Video 4 - "Applying NCCN Guidelines in the Treatment of mBC"

EP. 9 Applying NCCN Guidelines in the Treatment of mBC

Video 5 - "CDK4/6 Inhibitor Sequencing and NCCN Guidelines in mBC"

EP. 10 CDK4/6 Inhibitor Sequencing and NCCN Guidelines in mBC

Video 6 - "evaluating CDK4/6 inhibitor safety profiles"

EP. 11 Evaluating CDK4/6 Inhibitor Safety Profiles: An Analysis of Adverse Events

A panel of 4 experts

EP. 12 Navigating Financial Barriers: Cost-Saving Strategies and Patient Assistance Programs

A panel of 4 experts

EP. 13 Exploring Therapeutic Alternatives to CDK4/6 Inhibitors in Metastatic Breast Cancer

A panel of 4 experts

EP. 14 Academic and Community Practice Collaboration in mBC Treatment

A panel of 4 experts

EP. 15 Defining the Standard of Care for Early Breast Cancer Treatment

A panel of 4 experts on breast cancer

EP. 16 Balancing Clinical and Economic Factors in Early Breast Cancer Treatment

A panel of 4 experts on breast cancer

EP. 17 Alternative Treatments for eBC and mBC

A panel of 4 experts on breast cancer

EP. 18 Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective

A panel of 4 experts on breast cancer

EP. 19 Bridging the Gap: Multidisciplinary Collaboration in Early Breast Cancer Care

A panel of 4 experts on breast cancer

EP. 20 Key Takeaways on mBC and eBC

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Content

patient listening to doctor | Image Credit: Konstantin Yuganov | stock.adobe.com

Pharmacists’ Expanding Role in Optimizing Oral Endocrine and Targeted Breast Cancer Therapies

ByDanielle Valletti, Assistant Editor,Allison Butts, PharmD, BCOP

December 21st 2025

Image Credit: miss irine | stock.adobe.com | GLP-1 drug vials with heart symbol and syringe suggest hormone therapy for weight loss and diabetes. Medical chart shows health improvement.

Potential Benefits of GLP-1 Agonists in Reducing Chemotherapy-Related Toxicities in Breast Cancer

ByElvis Obomanu, MBBS, LMCC,Danielle Valletti, Assistant Editor

December 18th 2025

GLP-1 medicine vial representing advancements in weight loss treatment, metabolic disease management, and pharmaceutical innovation | Image Credit: Igor_Tichonow | stock.adobe.com

GLP-1 Agonists May Favorably Influence Metabolic Risk and Breast Cancer Outcomes

ByJoanne Mortimer, MD, FACP, FASCO,Danielle Valletti, Assistant Editor

December 17th 2025

Endocrine Therapy Supports Safe Radiation De-Escalation in Early-Stage Breast Cancer

ByDanielle Valletti, Assistant Editor,Jose Bazan, MD

December 16th 2025

MammaPrint Identifies Patients Who Benefit From Anthracyclines in Early-Stage Breast Cancer

ByDanielle Valletti, Assistant Editor,William Audeh, MD

December 15th 2025

Trending on Pharmacy Times

December 2025 Product Updates

Interview with Sa'ed al-Olimat, PharmD: How Pharmacists are Shaping the Future of Psychedelic Therapy

A Healthy Gut Could Improve Mental Health

Reimagining Pharmacy: A Call to Action for Pharmacy Professionals

FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia